KPIs & Operating Metrics(New)
Assets By SegmentBreakdown Of AssetsContractual Obligations AnnualCost Of SalesEmployee StatisticsGross Margin %Gross ProfitIncome Before Income TaxInternational Revenue BreakdownMed Surg And Neurotechnolgy Revenue By GeographyMedsurg And Neurotechnology Revenue By Geography AnnualMed Surg Revenue By CategoryMed Surg Revenue By Category AnnualMed Surg Revenue By Geography Annual (Deprecated)Med Surg Revenue By Geography (Deprecated)Neurotechnology And Spine Revenue By Category AnnualNeurotechnology And Spine Revenue By Category (Deprecated)Neurotechnology And Spine Revenue By Geography Annual (Deprecated)Neurotechnology And Spine Revenue By Geography (Deprecated)Non Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Income By SegmentOperating Income By Segment AnnualOperating Margin By Segment %Operating Margin By Segment Annual %OPEX As A% Of Total Revenue %OPEX SegregationOrthopaedics And Spine Revenue By GeographyOrthopaedics And Spine Revenue By Geography AnnualOrthopaedics Revenue By CategoryOrthopaedics Revenue By Category AnnualOrthopaedics Revenue By Geography Annual (Deprecated)Orthopaedics Revenue By Geography (Deprecated)Property, Plant And Equipment, Net BreakdownProperty, Plant And Equipment, Net By GeographyRevenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By ProductRevenue By Product %Revenue By Product AnnualRevenue By Product Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stryker (SYK) Gross Profit (2016 - 2025)

Stryker (SYK) has disclosed Gross Profit for 17 consecutive years, with $4.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Gross Profit rose 10.88% to $4.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $16.1 billion, a 11.25% increase, with the full-year FY2025 number at $16.1 billion, up 284.88% from a year prior.
  • Gross Profit was $4.6 billion for Q4 2025 at Stryker, up from $3.9 billion in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $4.6 billion in Q4 2025 to a low of $2.5 billion in Q1 2021.
  • A 5-year average of $3.3 billion and a median of $3.2 billion in 2022 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: surged 79.07% in 2021, then increased 1.95% in 2022.
  • Stryker's Gross Profit stood at $3.0 billion in 2021, then rose by 6.27% to $3.2 billion in 2022, then rose by 14.43% to $3.7 billion in 2023, then rose by 12.72% to $4.2 billion in 2024, then grew by 10.88% to $4.6 billion in 2025.
  • Per Business Quant, the three most recent readings for SYK's Gross Profit are $4.6 billion (Q4 2025), $3.9 billion (Q3 2025), and $3.8 billion (Q2 2025).